Reversal of cirrhotic decompensation: re-compensation
10.3760/cma.j.issn.1007-3418.2019.12.002
- VernacularTitle: 肝硬化失代偿的逆转：再代偿
- Author:
Zhiying HE
1
;
Bingqiong WANG
;
Hong YOU
Author Information
1. Liver Research Center, Beijing Friendship Hospital, Capital Medical University & National Clinical Research Center for Digestive Diseases, Beijing 100050, China
- Publication Type:Journal Article
- Keywords:
Liver cirrhosis;
Reversal;
Re-compensation
- From:
Chinese Journal of Hepatology
2019;27(12):915-918
- CountryChina
- Language:Chinese
-
Abstract:
Liver cirrhosis is the end stage of chronic liver disease and as the disease progresses to decompensated stage cirrhosis, the mortality rate of patients’ increases significantly. The goal of controlling the etiology or treatment in decompensated stage cirrhosis is to improve the liver function of patients, stabilize the disease condition or reverse decompensation, reduce the recurrence of decompensated events and reduce the mortality rate. However, presently, there are few studies on the reversal of cirrhotic decompensation/ re-compensation. Moreover, the effect of prophylactic treatment on re-compensation, evaluation indicators and duration of re-compensation, structure of hepatic lobules and whether microvessels can be reconstructed are unclear, so require further research.
